| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | dexamethasone | CTRPv2 | pan-cancer | AAC | 0.0013 | 1 |
| mRNA | sirolimus:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0012 | 1 |
| mRNA | purmorphamine | CTRPv2 | pan-cancer | AAC | -0.0013 | 1 |
| mRNA | BRD-K27986637 | CTRPv2 | pan-cancer | AAC | -0.0018 | 1 |
| mRNA | BRD-K99584050 | CTRPv2 | pan-cancer | AAC | -0.0013 | 1 |
| mRNA | BAY 61-3606 | GDSC1000 | pan-cancer | AAC | -0.00073 | 1 |
| mRNA | isoliquiritigenin | CTRPv2 | pan-cancer | AAC | 0.0013 | 1 |
| mRNA | cabozantinib | CTRPv2 | pan-cancer | AAC | 0.00061 | 1 |
| mRNA | ATRA | GDSC1000 | pan-cancer | AAC | -0.00052 | 1 |
| mRNA | VX-11e | GDSC1000 | pan-cancer | AAC | -0.00044 | 1 |